Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studies

INTRODUCTION: Androgen deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) analogs is a standard treatment for advanced prostate cancer. GnRH analog therapy can reduce testosterone to “castrate” levels, historically defined as <50 ng/dL. With the advent of newer assays, a lower t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Rep Urol
Autors principals: Spitz, Aaron, Gittelman, Marc, Karsh, Lawrence I, Dragnic, Sanja, Soliman, Ahmed M, Lele, Aditya, Gruca, Damian, Norton, Michael
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5003568/
https://ncbi.nlm.nih.gov/pubmed/27602344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S111475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars